The causes of heart failure are complex, and almost all cardiovascular diseases can lead to the development of heart failure. The treatment of heart failure also consists of a wide range of therapeutic measures, ranging from pharmacologic therapy to device assistance to eventual cardiac shift. Most patients with heart failure, primarily those with systolic dysfunction, are treated with angiotensin-converting enzyme inhibitors (ACE I), Beta receptor blockers, diuretics, spironolactone (amphiregulin), and digoxin. ACE I can stop the production of angiotensin II, a vasoconstrictor, which is produced by the body during heart failure. ACE I can dilate blood vessels, reduce the load on the heart during contraction, and prevent the heart from overdoing work. It also improves heart function and prevents the heart from getting bigger. Diuretics drain the fluid retained by the body during heart failure, reducing the preload on the heart, decreasing edema, and reducing the symptoms of pulmonary bruising. Beta-blockers inhibit the sympathetic nervous system, reduce cardiac load, decrease the strength of the heart’s contraction, lower the heart rate and inhibit the occurrence of arrhythmias, allowing the heart to rest adequately. Digoxin, a digitalis analog, increases the force of contraction of the heart and helps improve symptoms. However, it is contraindicated in diastolic heart failure. Spironolactone (Advil), an aldosterone receptor blocker, can effectively inhibit the renin-angiotensin-aldosterone system (RAAS) RAAS system activation plays an important role in the development and progression of heart failure. Large clinical trials have demonstrated that effective inhibition of the RAAS reduces mortality in patients with heart failure. Device-assisted devices include: biventricular synchronized pacemakers, intracorporeal buried automatic defibrillators (ICDs), and left ventricular assist devices. Biventricular synchronous pacing: In the normal population, the contraction and diastole of the left and right ventricles of the heart are synchronized. In some patients with heart failure, there is asynchrony in the contraction and diastole of the left and right ventricles due to lesions in the myocardial tissue. This causes the pumping function of the heart to be affected, and the application of a pacemaker stimulates both the left and right ventricles to synchronize their contraction and diastole and improve heart function.